CDK6 and ovarian cancer: In this regard, CDK6 expression is substantially upregulated in ovarian cancer tissues compared to non-tumoral tissues, and its knockdown is associated with enhanced chemosensitivity of ovarian cancer cells to cisplatin (Duan et al., 2020[29]).